Membership Directory

Agios Pharmaceuticals

Category: Drug Development
Phone: 617-236-0535
Fax: 617-649-2003
Website: http://www.agios.com

Agios is s biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become addicted to using more nutrients than normal cells to ensure their survival and growth. Agios Pharmaceuticals is developing a deep pipeline of drug candidates that disrupt the growth and survival of cancer based on unique insights of the founders, scientific advisory board as well as building on decades of research in the fields of oncology and metabolism. The company’s initial focus is cancer, particularly targeting three key metabolic pathways – glycolysis (sugar metabolism), fatty acid metabolism, and autophagy (self-metabolism). Agios’ primary focus is in oncology, but the company’s platform will also be applicable to other therapeutics areas including autoimmune, inflammatory, and neurological diseases.

Back to list